Skip to main content
Clinical Trials/NCT05640934
NCT05640934
Completed
Phase 2

The Impact of Melatonin on the Postoperative Delirium in Geriatric Patients After Colorectal Surgeries. A Randomised Placebo-controlled Trial

Menoufia University1 site in 1 country100 target enrollmentDecember 10, 2022

Overview

Phase
Phase 2
Intervention
Melatonin
Conditions
Delirium in Old Age
Sponsor
Menoufia University
Enrollment
100
Locations
1
Primary Endpoint
Incidence of delirium occurrence
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The present study will evaluate the role of melatonin prophylaxis in delirium prevention in elderly patients undergoing colorectal procedures.

Detailed Description

This study is a prospective randomised double-blind placebo-controlled trial. Patients who meet the criteria for inclusion/exclusion will be evaluated. Melatonin tablets will be administered as a premedication to patients in the melatonin group. Patients in the control group will be given placebo tablets as a premedication. Fentanyl 1ug/kg and propofol 1-2 mg/kg will be used to induce anaesthesia. Atracurium 0.5 mg/kg will be used for the facilitation of endotracheal intubation. Isoflurane will be used to maintain anaesthesia and the depth of anaesthesia will be adjusted by a Bispectral index monitor. Postoperatively, the patients will be monitored for the development of delirium.

Registry
clinicaltrials.gov
Start Date
December 10, 2022
End Date
July 5, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Abd-Elazeem Abd-Elhameed Elbakry

Assistant professor

Menoufia University

Eligibility Criteria

Inclusion Criteria

  • American Society of Anaesthesiologists (ASA) I to III physical status
  • Elective colorectal procedures

Exclusion Criteria

  • Allergy to the research drugs,
  • Patients who have vision or hearing impairment
  • History of cerebral disorders
  • Uncorrected acid-base, fluid, and electrolyte abnormalities
  • History of central nervous system function affecting drugs.
  • Chronic sedative-hypnotic administration at least one month prior to surgery
  • Alcohol abuse
  • Patients with recorded preoperative nursing delirium screening score ≥ 2.

Arms & Interventions

Melatonin group

The patients will be given 5 mg melatonin the night before surgery, 12 hours before the scheduled time of surgery, followed by another 5 mg melatonin two hours before surgery.

Intervention: Melatonin

Control group

The patients will be premedicated with placebo tablets, which will be administered at the same times as the melatonin group.

Intervention: Placebo

Outcomes

Primary Outcomes

Incidence of delirium occurrence

Time Frame: Perioperative.

Nursing delirium - screening score. It scores five items,Each item is rated from 0 to 2 where 0, absent; 1, mild; 2, severe. A score ≥ 2 is considered to have delirium.

Secondary Outcomes

  • Blood transfusion needs(Perioperative)
  • Mean arterial blood pressure(Perioperative)
  • Heart rate(Perioperative)
  • Hypotension(Perioperative)
  • Hypoxia(Perioperative)
  • Intensity of pain(Perioperative)
  • Degree of Sedation(Perioperative.)

Study Sites (1)

Loading locations...

Similar Trials